{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:46:21Z","timestamp":1772516781518,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K14675"],"award-info":[{"award-number":["JP23K14675"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clim.2025.110644","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T15:22:35Z","timestamp":1763911355000},"page":"110644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cross-reactive HERV-W and EBV peptides elicit antibody responses in MS patients and synergistically exacerbate neuroinflammation in EAE"],"prefix":"10.1016","volume":"283","author":[{"given":"Davide","family":"Cossu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamami","family":"Sakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ruberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110644_bb0005","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1177\/13524585251368687","article-title":"Prevalence of multiple sclerosis and disease-modifying therapy use in older adults in the United States, 2011-2021","volume":"31","author":"Li","year":"2025","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clim.2025.110644_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00281-002-0105-z","article-title":"Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination","volume":"24","author":"Tsunoda","year":"2002","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.clim.2025.110644_bb0015","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1007\/s10072-025-08385-3","article-title":"A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study","volume":"46","author":"Ghezzi","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clim.2025.110644_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70501","article-title":"EBV latency programs: molecular and epigenetic regulation and its role in disease pathogenesis","volume":"97","author":"Lyu","year":"2025","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.clim.2025.110644_bb0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424986122","article-title":"Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls","volume":"122","author":"Sattarnezhad","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2025.110644_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2021.07.007","article-title":"Impact of genetic variation on the molecular mimicry between Anoctamin-2 and Epstein-Barr virus nuclear antigen 1 in multiple sclerosis","volume":"238","author":"Sepulveda","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2025.110644_bb0035","doi-asserted-by":"crossref","first-page":"eadg3032","DOI":"10.1126\/sciadv.adg3032","article-title":"Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis","volume":"9","author":"Thomas","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.clim.2025.110644_bb0040","doi-asserted-by":"crossref","first-page":"1505239","DOI":"10.3389\/fimmu.2024.1505239","article-title":"Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression","volume":"15","author":"Ruberto","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110644_bb0045","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s12250-021-00372-0","article-title":"Human endogenous retrovirus type W envelope from multiple sclerosis demyelinating lesions shows unique solubility and antigenic characteristics","volume":"36","author":"Charvet","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.clim.2025.110644_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080128","article-title":"Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice","volume":"8","author":"Perron","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2025.110644_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2024.105431","article-title":"HERV-W ENV transcription in B cells predicting symptomatic COVID-19 and risk for long COVID can express a full-length protein despite stop codon in mRNA from chromosome X via a ribosome readthrough","volume":"27","author":"Brunel","year":"2025","journal-title":"Microbes Infect."},{"key":"10.1016\/j.clim.2025.110644_bb0060","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JVI.73.2.1175-1185.1999","article-title":"Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family","volume":"73","author":"Blond","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2025.110644_bb0065","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1038\/s41598-017-03370-z","article-title":"Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system","volume":"7","author":"Cossu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110644_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106658","article-title":"The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis","volume":"103","author":"Tena-Cucala","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clim.2025.110644_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2025.110644_bb0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2025.110644_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417151","article-title":"Epstein-Barr virus and human endogenous retrovirus in Japanese patients with autoimmune demyelinating disorders","volume":"24","author":"Cossu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110644_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910697","article-title":"Impact of Epstein-Barr virus nuclear antigen 1 on neuroinflammation in PARK2 knockout mice","volume":"25","author":"Cossu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110644_bb0095","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","article-title":"Natural autoantibodies","volume":"7","author":"Coutinho","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2025.110644_bb0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/eji.201142010","article-title":"CD8+ T-cell cross-competition is governed by peptide-MHC class I stability","volume":"42","author":"Galea","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2025.110644_bb0105","article-title":"The nature of genetic and environmental susceptibility to multiple sclerosis","volume":"16","author":"Goodin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2025.110644_bb0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbi.2024.10.020","article-title":"Ancient viral DNA in the human genome linked to neurodegenerative diseases","volume":"123","author":"Duarte","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.clim.2025.110644_bb0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/pathogens2010153","article-title":"Humanized mouse models of epstein-barr virus infection and associated diseases","volume":"2","author":"Fujiwara","year":"2013","journal-title":"Pathogens"},{"key":"10.1016\/j.clim.2025.110644_bb0120","doi-asserted-by":"crossref","first-page":"1487523","DOI":"10.3389\/fimmu.2024.1487523","article-title":"In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis","volume":"15","author":"Vasilenko","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:28:26Z","timestamp":1769128106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625002190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"alternative-id":["S1521661625002190"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110644","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-reactive HERV-W and EBV peptides elicit antibody responses in MS patients and synergistically exacerbate neuroinflammation in EAE","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110644"}}